• Search
  • Helpdesk
  • Sales contact

Are barriers to eCOA adoption true hurdles?

12 December 2019

Over recent years, as an industry, we seem to have created a paradox: we increase investment in technological developments, but the adoption rate remains low. In 2019, as few as 31% of sponsors were familiar with and used mobile health technologies and virtual approaches in clinical trials.1

Electronic Clinical Outcome Assessment (eCOA) solutions are increasingly preferred to paper questionnaires for endpoint data collection in clinical and epidemiological studies. However, insuperable barriers hinder the widespread use of eCOA.

What are these barriers and are they wrongly perceived as being insurmountable? Mrs Estelle Haenel, Medical Director at Kayentis, talks through those misconceptions.


Discover the full videos and transcripts:

patient-training-and-retraining-plan
data-might-be-lost-due-to-device-failure


References
[1] https://www.clinicalleader.com/doc/tactics-to-overcome-technology-innovation-adoption-challenges-in-clinical-research-0001

Follow us on social media
Subscribe to our newsletter
About the author
Meet us at the following events

Digital Biomarkers in Clinical Trials Summit

26 JUNE 2024 • ROCHE BUILDING 1 • BASEL
https://digitalbiomarkers.panagorapharma.com/    

Mobile in Clinical Trials

16 SEPT 2024 • Philadelphia, USA
https://mobileinclinicaltrials.com/

DPharm 2024

17-18 SEPT 2024 • Philadelphia, USA
https://dpharmconference.com/   

SCDM 2024

29 SEPT - 2 OCT 2024 • Boston, USA
https://scdmlive.org/annual-conference-2024/      

ISOQOL 2024

13-16 OCT 2024 • Cologne, Germany
https://www.isoqol.org/    

CNS SUMMIT 2024

10-13 NOV 2024 • Cologne, Germany
https://cnssummit.org/the-summit/  

DMB 2024

13 NOV 2024 • Paris, France
https://dmb-asso.org/

SCOPE 2025

FEB 3-6 2025 • Orlando, USA
Booth #931 https://www.scopesummit.com/